CIK: 0001232621 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value ($000): $502,375 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS INC | 7,907,087 | $122,718 | 24.4% | $15.91 | 0.0% | COM | 427746102 |
| RCKT | ROCKET PHARMACEUTICALS INC | 2,531,800 | $112,133 | 22.3% | $16.31 | +166.3% | COM | 77313F106 |
| ANAB | ANAPTYSBIO INC | 2,628,678 | $68,162 | 13.6% | $21.51 | +11.4% | COM | 032724106 |
| — | ODONATE THERAPEUTICS INC | 15,514,566 | $54,146 | 10.8% | $24.10 | — | COM | 676079106 |
| — | LA JOLLA PHARMACEUTICAL CO | 10,049,224 | $43,011 | 8.6% | $9.96 | — | COM | 503459604 |
| — | APTEVO THERAPEUTICS INC | 1,760,000 | $39,477 | 7.9% | $36.65 | — | COM NEW | 03835L207 |
| — | VINCERX PHARMA INC | 1,030,634 | $13,388 | 2.7% | $16.05 | — | COM NEW | 92731L106 |
| CHRS | COHERUS BIOSCIENCES INC | 650,000 | $8,990 | 1.8% | $17.90 | -20.9% | COM | 19249H103 |
| ALT | ALTIMMUNE INC | 783,407 | $7,717 | 1.5% | $13.67 | 0.0% | COM NEW | 02155H200 |
| — | CHEMOCENTRYX INC | 500,000 | $6,695 | 1.3% | $13.39 | — | COM | 16383L106 |
| RVPH | REVIVA PHARMACEUTCLS HLDGS I | 1,200,000 | $5,832 | 1.2% | $5.04 | 0.0% | COM | 76152G100 |
| — | ITEOS THERAPEUTICS INC | 219,396 | $5,628 | 1.1% | $25.65 | — | COM | 46565G104 |
| — | BCTG ACQUISITION CORP | 468,750 | $5,334 | 1.1% | $10.36 | — | COM | 05492W103 |
| EQ | EQUILLIUM INC | 600,000 | $3,534 | 0.7% | $5.23 | +20.6% | COM | 29446K106 |
| RLMD | RELMADA THERAPEUTICS INC | 100,000 | $3,201 | 0.6% | $28.22 | +23.1% | COM | 75955J402 |
| — | NEXTCURE INC | 300,000 | $2,409 | 0.5% | $8.03 | — | COM | 65343E108 |